Jeff Moffit, PhD, DABT

Jeff Moffit, PhD, DABT is an experienced professional in the field of nonclinical drug safety and translational sciences. Jeff has held various roles in the industry since 2007. From 2007 to 2013, they worked at Boehringer Ingelheim as a Principal Scientist, Nonclinical Drug Safety US. From 2013 to 2016, they worked at FORUM Pharmaceuticals as an Associate Director, Head of Toxicology. From 2016 to 2017, they worked at Alnylam Pharmaceuticals as a Director, Regulatory Toxicology. From 2017 to 2019, they worked at Bioverativ (acquired by Sanofi in Feb 2019) as an Executive Director, Head of Toxicology. From 2019 to 2022, they worked at Generation Bio as a Vice President, Head of Nonclinical Drug Safety & Translational Sciences. Currently, they work at Carbon Biosciences as a Vice President, Head of Nonclinical Development.

Jeff Moffit, PhD, DABT received their Bachelor of Science in Biochemistry from Rutgers University. Jeff then went on to obtain their Doctor of Philosophy in Pharmacology and Toxicology from the University of Connecticut in 2006. Following their PhD, they were a Post Doctoral Research Fellow in Reproductive Toxicology at Brown University from 2006 to 2007.